Singular Genomics Systems Performance

Singular Genomics Relative Risk vs. Return Landscape

If you would invest  2,001  in Singular Genomics Systems on November 9, 2025 and sell it today you would earn a total of  0.00  from holding Singular Genomics Systems or generate 0.0% return on investment over 90 days. Singular Genomics Systems is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Singular, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.

Singular Genomics Target Price Odds to finish over Current Price

Given the investment horizon of 90 days Singular Genomics Systems has a beta of -0.0793. This indicates as returns on the benchmark increase, returns on holding Singular Genomics are expected to decrease at a much lower rate. During a bear market, however, Singular Genomics Systems is likely to outperform the market. Additionally Singular Genomics Systems has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.

Predictive Modules for Singular Genomics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Singular Genomics Systems. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.

Hype Prediction Low Estimated High 20.01 20.01 20.01 Details

Intrinsic Valuation Low Real High 17.25 17.25 22.01 Details

Naive Forecast Low Next High 20.30 20.30 20.30 Details

Bollinger Band Projection (param) Lower Middle Band Upper 19.42 19.79 20.17 Details

Singular Genomics Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Singular Genomics is not an exception. The market had few large corrections towards the Singular Genomics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Singular Genomics Systems, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Singular Genomics within the framework of very fundamental risk indicators.

Singular Genomics Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Singular Genomics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Singular Genomics Systems can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.

Singular Genomics Price Density Drivers

Singular Genomics Fundamentals Growth

Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

If you are still planning to invest in Singular Genomics Systems check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Singular Genomics' history and understand the potential risks before investing.